In MEG3 overexpressing bladder cancer, cisplatin could significantly induce cell apoptosis, down-regulate bcl2 expression and up-regulate cleaved-caspase-3 and bax expression [20]. This evidence concerns the gene BCL2 and urinary bladder carcinoma.